Therapeutic Asset Ratings
368 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
flt3 ligand
Pancreatic Cancer
Washington University School of Medicine
P2
CC
(44)
Futibatinib
Pancreatic Neoplasm
Taiho Oncology, Inc.
P2
CC
(44)
NC 410
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(44)
Rintatolimod
Pancreatic Neoplasm
AIM ImmunoTech Inc.
P2
CC
(43)
Urelumab
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(43)
Avelumab
Pancreatic Neoplasm
Fate Therapeutics
P1/2
CC
(43)
e-602
Pancreatic Neoplasm
Palleon Pharmaceuticals, Inc.
P1/2
CC
(42)
H-gamma1 heavy chain Homo sapiens (1-447) [VH (Homo sapiens IGHV4-59*01 (99.0%) -(IGHD) -IGHJ3*02 (93.3%) T125>I (114), CDR-IMGT [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, CH3 D12, L14, 9-G1v21 CH2 Y15.1, T16, E18 (CH1 K120 (214) (118-215), hinge 1-15 (216-230), CH2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), CH3 D12 (356), L14 (358) (341-445), CHS (446-447)) (118-447)], (220-214')-disulfide with L-kappa light chain Homo sapiens (1'-214') [V-KAPPA (Homo sapiens IGKV3-11*01 (96.8%) -IGKJ4*01 (100%), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (CKAPPA A45.1 (153'), V101 (191')) (108'-214')]; dimer (226-226'':229-229'')-bisdisulfide, produced in a cell line derived from Chinese hamster ovary (CHO) cells, glycoform alfa
Pancreatic Neoplasm
Kineta Inc.
P1/2
CC
(42)
FLUORTHANATRACE F-18
Pancreatic Neoplasm
Abramson Cancer Center at Penn Medicine
P1
CC
(41)
kd-496
Pancreatic Neoplasm
Peking University
P1
CC
(41)
Tcr-T Cells
Pancreatic Neoplasm
Beijing DCTY Biotech Co.,Ltd.
P1
CC
(41)
[111In]In-DOTA-ANTI-CEA antibody
Pancreatic Neoplasm
Radboud University Medical Center
P1/2
CC
(40)
64cu-lnth-1363s
Pancreatic Neoplasm
Lantheus Medical Imaging
P1/2
CC
(40)
a2b530
Pancreatic Neoplasm
A2 Biotherapeutics Inc.
P1/2
CC
(40)
Agen2373
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CC
(40)
AMXI-5001
Pancreatic Neoplasm
AtlasMedx, Incorporated
P1/2
CC
(40)
Anti-Hcd70 Car Transduced Pbl
Pancreatic Neoplasm
National Cancer Institute (NCI)
P1/2
CC
(40)
Anti-Kras G12V Mtcr Pbl
Pancreatic Neoplasm
National Cancer Institute (NCI)
P1/2
CC
(40)
Ast-001
Pancreatic Neoplasm
Ascentawits Pharmaceuticals, Ltd
P1/2
CC
(40)
azd5305
Pancreatic Neoplasm
AstraZeneca
P1/2
CC
(40)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)-
Pancreatic Neoplasm
VM Oncology, LLC
P1/2
CC
(40)
bhb810
Pancreatic Neoplasm
BigHat Biosciences, Inc.
P1/2
CC
(40)
bi 853520
Pancreatic Neoplasm
InxMed (Shanghai) Co., Ltd.
P1/2
CC
(40)
bnt141
Pancreatic Neoplasm
BioNTech SE
P1/2
CC
(40)
BNT321
Pancreatic Neoplasm
BioNTech SE
P1/2
CC
(40)
Showing 151 to 175 of 368 assets
Previous
Page 7 of 15
Next
